Hiperhomosisteinemi ve karaciğer yağlanması: Eski ikilemin “yumurta mı tavuk mu?” karaciğere uygulanması

Year 2011, Volume: 10 Issue: 3, 131 - 134, 01.12.2011

Engin Altıntaş

Abstract

İletişim:Engin ALTINTAŞ Mersin Üniversitesi Tıp Fakültesi Zeytinlibahçe Cad. Eskiotogar Yanı İç Hastalıkları A.D. 33079 Mersin, Türkiye • Tel: + 90 324 337 43 00 Fax: + 90 324 336 71 17 • E-mail: [e-mail]

Keywords

-

Hyperhomocysteinemia and liver steatosis: Modification of “the chicken or the egg?” dilemma to the liver

Abstract

Homocysteine (Hcy) is a sulfur-containing amino acid that is formed as an intermediary in methionine metabolism (1). Extensive evidence shows that elevated plasma Hcy concentration, a reflection of impaired cellular metabolism, can be considered as an independent risk factor for atherothrombotic vascular disease (2). This condition has been observed in 20% to 30% of patients with premature arteriosclerosis and in 21% of the general population above a certain age (3,4). Three enzymes utilize Hcy as a substrate: methionine synthase (MS) and betaine-homocysteine methyltransferase (BHMT), which convert Hcy back to methionine, and cystathionine β-synthase (CBS), the first enzyme in the transsulfuration pathway (1) (Figure 1)

Keywords

Hyperhomocysteinemia, steatosis, Modification

References

• Finkelstein JD. Methionine metabolism in mammals. J Nutr Biochem 1990;1:228-36.
• Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998;49:31-62.
• Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996;27:517-27.
• Selhub J, Jacques PF, Wilson PW, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly populations. J Am Med Assoc 1993;270:2693-8.
• Mato JM, Alvarez L, Ortiz P, Pajares MA. S-Adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacol Ther 1997;73:265-80.
• Cravo ML, Gloria LM, Selhub J, et al. Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitamin B-12, and vitamin B-6 status. Am J Clin Nutr 1996;63:220-4.
• Hultberg B, Berglund M, Andersson A, Frank A. Elevated plasma homocysteine in alcoholics. Alcohol Clin Exp Res 1993;17:687-9.
• Lambert D, Benhayoun S, Adjalla C, et al. Alcoholic cirrhosis and cobalamin metabolism. Digestion 1997;58:64-71.
• Halsted CH, Villanueva J, Chandler CJ, et al. Ethanol feeding of micropigs alters methionine metabolism and increases hepatocellular apoptosis and proliferation. Hepatology 1996;23:497-505.
• Varela-Moreiras G, Alonso-Aperte E, Rubio M, et al. Carbon tetrachloride-induced hepatic injury is associated with global DNA hypomethylation and homocysteinemia: effect of S-adenosylmethionine treatment. Hepatology 1995;22:1310-5.
• Lentz SR. Homocysteine and vascular dysfunction. Life Sci 1997;61:1205-15.
• McCully KS. Homocysteine and vascular disease. Nature Med 1996;2:386-9.
• Tyagi SC. Homocyst(e)ine and heart disease: pathophysiology of extracellular matrix. Clin Exp Hypertens 1999;21:181-98.
• Tsai JC, Perrella MA, Yoshizumi M, et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA 1994;91:6369-73.
• Majors A, Ehrhart LA, Pezacka EH. Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells. Arterioscler Thromb Vasc Biol 1997;17:2074-81.
• Karmin O, Lynn EG, Chung YH, et al. Homocysteine stimulates the production and secretion of cholesterol in hepatic cells. Biochim Biophys Acta 1998;1393:317-24.
• Yi P, Melnyk S, Pogribna M, et al. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 2000;275:29318-23.
• Garcia-Tevijano ER, Berasain C, Rodríguez JA, et al. Hyperhomocysteinemia in liver cirrhosis mechanisms and role in vascular and hepatic fibrosis. Hypertension 2001;38:1217-21.
• Adinolfi LE, Ingrosso D, Cesaro G, et al. Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients. Hepatology 2005;41:995-1003.
• Sazci A, Ergul E, Kaya G, Kara I. Genotype and allele frequencies of the polymorphic methylenetetrahydrofolate reductase gene in Turkey. Cell Biochem Funct 2005;23:51-4.
• Watanabe M, Osada J, Aratani Y, et al. Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocysteinemia. Proc Natl Acad Sci USA 1995;92:1585-9.
• Gülflen M, Yeflilova Z, Ba¤c› S, et al. Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2005;20: 1448-55.
• Werstuck GH, Lentz SR, Dayal S, et al. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest 2001;107: 1263-73.
• Golbahar J, Aminzadeh MA, Kassab SE, Omrani GR. Hyperhomocysteinemia induces insulin resistance in male Sprague-Dawley rats. Diabetes Res Clin Pract 2007;76:1-5.
• Altinova AE, Toruner F, Bukan N, et al. Decreased plasma adiponectin is associated with insulin resistance and HDL cholesterol in overweight subjects. Endocr J 2007;54:221-6.
• Meigs JB, Jacques PF, Selhub J, et al. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham Offspring Study. Diabetes Care 2001;24:1403-10.
• Ascencio C, Torres N, Isoard-Acosta F, et al. Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats. J Nutr 2004;134:522-9.
• Song Z, Zhou Z, Uriarte S, et al. S-adenosylhomocysteine sensitizes to TNF-alpha hepatotoxicity in mice and liver cells: a possible etiological factor in alcoholic liver disease. Hepatology 2004;40:989-97.
• Wang G, Siow YL, O K. Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase C. Biochem J 2000;352:817-26.
• Torres L, García-Trevijano ER, Rodríguez JA, et al. Induction of TIMP-1 expression in rat hepatic stellate cells and hepatocytes: a new role for homocysteine in liver fibrosis. Biochim Biophys Acta 1999;1455:12-22.
• Duong FH, Filipowicz M, Tripodi M, et al. Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A. Gastroenterology 2004;126:263-77.
• Kharbanda KK. Role of transmethylation reactions in alcoholic liver disease. World J Gastroenterol 2007;13:4947-54.